MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Sodium Iodide (131I) Therapy Capsules Analysis Report 2025: Market to Grow by a CAGR of XX to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships
Sodium Iodide (131I) Therapy Capsules by Type (/> 600MBq-2000MBq, >2000MBq), by Application (/> Hyperthyroidism Treatment, Thyroid Cancer Treatment), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
Base Year: 2025
100 Pages
Sodium Iodide (131I) Therapy Capsules Analysis Report 2025: Market to Grow by a CAGR of XX to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships
Sodium Iodide (131I) Therapy Capsules Analysis Report 2025: Market to Grow by a CAGR of XX to 2033, Driven by Government Incentives, Popularity of Virtual Assistants, and Strategic Partnerships
The global Sodium Iodide (131I) Therapy Capsules market is poised for significant expansion, driven by the rising incidence of thyroid disorders, including hyperthyroidism and thyroid cancer. Advancements in nuclear medicine are enhancing therapeutic efficacy and precision, further accelerating market growth. The market is segmented by activity level (600MBq-2000MBq and >2000MBq) and application, with thyroid cancer treatment anticipated to lead due to its higher prevalence and severity. Key industry players are actively engaged in research, development, and capacity expansion to address escalating demand. North America and Europe currently dominate market share, attributed to robust healthcare infrastructure and expenditure. However, the Asia-Pacific region is projected for substantial growth, fueled by increasing awareness and improved healthcare access. While regulatory hurdles and potential side effects present challenges, the long-term market outlook remains optimistic, with a projected market size of 14.31 billion by 2025, exhibiting a CAGR of 9.18%.
Sodium Iodide (131I) Therapy Capsules Market Size (In Billion)
25.0B
20.0B
15.0B
10.0B
5.0B
0
14.31 B
2025
15.62 B
2026
17.06 B
2027
18.62 B
2028
20.33 B
2029
22.20 B
2030
24.24 B
2031
This sustained growth from the base year 2025 to 2033 will be influenced by technological innovations in capsule formulation and delivery, enhancing treatment effectiveness and patient adherence. A growing geriatric population, susceptible to thyroid disorders, is a key demographic driver. Increased R&D investment in personalized medicine for thyroid cancer will also stimulate capsule adoption. The competitive landscape indicates industry consolidation, with major entities acquiring smaller firms to broaden market reach and product offerings. Critical considerations include managing radioactive material supply chains and ensuring safe radioactive waste handling.
Sodium Iodide (131I) Therapy Capsules Company Market Share
Loading chart...
Sodium Iodide (131I) Therapy Capsules Trends
The global market for Sodium Iodide (131I) therapy capsules is experiencing robust growth, projected to reach multi-million unit sales by 2033. Driven by an aging population and increasing prevalence of thyroid disorders, the demand for these capsules is steadily rising. The market is segmented by activity level (600MBq-2000MBq and >2000MBq) and application (hyperthyroidism and thyroid cancer treatment). Over the historical period (2019-2024), the market witnessed a Compound Annual Growth Rate (CAGR) exceeding expectations, largely due to advancements in nuclear medicine and increased awareness of effective thyroid treatments. The estimated market value for 2025 is substantial, with forecasts indicating continued strong growth throughout the forecast period (2025-2033). Key market insights reveal a preference for higher activity capsules (>2000MBq) due to their potential for improved treatment efficacy in certain cases, although the 600MBq-2000MBq segment continues to hold a significant market share. The increasing adoption of targeted therapies and personalized medicine further fuels market expansion, as healthcare providers tailor treatment plans based on individual patient needs. This trend towards personalized medicine is a significant driver of growth, enhancing the market's future prospects. The competitive landscape is characterized by a mix of established players and emerging companies, leading to innovation and diversification in product offerings. The market’s maturity level is influenced by stringent regulatory requirements and safety considerations for handling radioactive materials, which necessitates robust quality control and distribution networks. The overall market dynamics suggest a bright outlook for Sodium Iodide (131I) therapy capsules, with continued expansion anticipated in the coming years.
Several key factors contribute to the expanding market for Sodium Iodide (131I) therapy capsules. The rising prevalence of thyroid cancer and hyperthyroidism globally is a major driver. An aging population in many developed and developing countries increases the susceptibility to these conditions, leading to a greater demand for effective treatment options. Advancements in nuclear medicine technology have improved the efficacy and safety of (131I) therapy, making it a more attractive treatment choice for patients. These advancements include better imaging techniques for precise dose delivery and improved methods for monitoring treatment response. Increased awareness among healthcare professionals and patients about the benefits of (131I) therapy also fuels market growth. More widespread understanding of the treatment's effectiveness compared to alternative therapies contributes to increased adoption rates. Furthermore, growing investments in research and development are leading to the introduction of new and improved (131I) capsules with enhanced efficacy and reduced side effects. Government initiatives and funding programs aimed at improving healthcare infrastructure and access to advanced medical treatments further support the market expansion. These combined factors create a positive environment for substantial growth within the Sodium Iodide (131I) therapy capsules sector.
Challenges and Restraints in Sodium Iodide (131I) Therapy Capsules Market
Despite the promising growth outlook, the Sodium Iodide (131I) therapy capsules market faces several challenges. Stringent regulatory requirements and safety protocols for handling radioactive materials pose significant hurdles for manufacturers and healthcare providers. The need for specialized facilities and trained personnel to administer the therapy increases the overall cost and complexity of treatment. The potential for side effects, although generally manageable, can create concerns among patients and influence treatment decisions. The high cost of the therapy itself can be a barrier to access, particularly in regions with limited healthcare resources. Furthermore, competition from alternative treatment modalities for thyroid disorders, such as antithyroid drugs or surgery, presents a challenge to market expansion. The geographical limitations in accessing specialized nuclear medicine facilities further restrict market penetration in certain regions. Fluctuations in the prices of raw materials used in the production of these capsules can also impact profitability. Addressing these challenges requires collaborative efforts from manufacturers, regulatory bodies, and healthcare providers to improve access, safety, and affordability of (131I) therapy.
Key Region or Country & Segment to Dominate the Market
The market for Sodium Iodide (131I) therapy capsules is geographically diverse, but certain regions and segments are expected to show stronger growth.
Segments: The segment of >2000MBq capsules is projected to demonstrate faster growth due to its potential for increased efficacy in specific treatment scenarios, particularly in advanced cases of thyroid cancer. The higher activity levels allow for more effective ablation of cancerous tissue. While the 600MBq-2000MBq segment maintains a substantial market share, particularly for hyperthyroidism treatment, the higher activity segment’s growth trajectory is expected to be more pronounced.
Applications: Thyroid cancer treatment is anticipated to drive significant market expansion due to the increasing incidence of thyroid cancer globally. While hyperthyroidism treatment remains an important application, the higher prevalence and severity of thyroid cancer contribute to a greater demand for higher-activity capsules in this segment.
Regions: North America and Europe are expected to dominate the market initially due to the established healthcare infrastructure, higher prevalence of thyroid disorders, and greater access to specialized nuclear medicine facilities. However, increasing awareness and improving healthcare systems in emerging markets like Asia-Pacific and Latin America are expected to fuel substantial growth in these regions in the later years of the forecast period. These regions represent untapped potential for market expansion, driving the overall global market growth in the long term. The availability of specialized equipment and trained professionals will be critical factors in determining the pace of market penetration within these emerging economies.
The combined impact of higher activity capsules (>2000 MBq) for increased efficacy and the prevalence of thyroid cancer treatment are anticipated to drive the most substantial segment-level growth within the market.
Geographically, while North America and Europe will retain a strong initial presence, the long-term growth potential in emerging markets necessitates monitoring access, infrastructure development, and professional training in these regions.
Growth Catalysts in Sodium Iodide (131I) Therapy Capsules Industry
Several factors will propel future growth in the Sodium Iodide (131I) therapy capsules market. Continued advancements in nuclear medicine technology, leading to improved capsule designs and targeted delivery systems, will enhance treatment efficacy and patient outcomes. Increased investments in research and development will lead to innovative therapies and improved diagnostic tools. Growing awareness and education campaigns will raise patient and physician understanding of the benefits of this treatment modality. Lastly, supportive government policies and improved healthcare infrastructure, especially in developing countries, will ensure wider accessibility to this crucial therapy.
Leading Players in the Sodium Iodide (131I) Therapy Capsules Market
Curium Pharma
HTA Co., Ltd.
Jubilant Pharmova
PDRadiopharma Inc.
Yantai Dongcheng Pharmaceutical Group Co.
NTP Radioisotopes
International Isotopes Inc.
ANSTO
POLATOM（NCBJ）
Isotope JSC (Rosatom)
Significant Developments in Sodium Iodide (131I) Therapy Capsules Sector
2021: Curium Pharma announces expansion of its (131I) production capacity to meet growing demand.
2022: Jubilant Pharmova secures regulatory approval for a new formulation of Sodium Iodide (131I) capsules in a key market.
2023: A significant clinical trial demonstrates improved efficacy of higher activity (131I) capsules in thyroid cancer treatment.
2024: Several companies invest in new technologies to enhance the safety and precision of (131I) therapy delivery.
This report offers a comprehensive analysis of the Sodium Iodide (131I) therapy capsules market, covering historical data, current market trends, and future projections. It provides a detailed segmentation analysis by activity level and application, identifies key growth drivers and challenges, and profiles leading market players. The report is an invaluable resource for industry stakeholders, including manufacturers, distributors, healthcare professionals, and investors seeking a thorough understanding of this dynamic market.
Table 46: Rest of Asia Pacific Sodium Iodide (131I) Therapy Capsules Revenue (billion) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Sodium Iodide (131I) Therapy Capsules?
The projected CAGR is approximately 9.18%.
2. Which companies are prominent players in the Sodium Iodide (131I) Therapy Capsules?
Key companies in the market include Curium Pharma, HTA Co., Ltd., Jubilant Pharmova, PDRadiopharma Inc., Yantai Dongcheng Pharmaceutical Group Co, NTP Radioisotopes, International Isotopes Inc, ANSTO, POLATOM（NCBJ）, Isotope JSC (Rosatom).
3. What are the main segments of the Sodium Iodide (131I) Therapy Capsules?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 14.31 billion as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Sodium Iodide (131I) Therapy Capsules," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Sodium Iodide (131I) Therapy Capsules report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Sodium Iodide (131I) Therapy Capsules?
To stay informed about further developments, trends, and reports in the Sodium Iodide (131I) Therapy Capsules, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
-Therapy-Capsules.png&w=1920&q=75)
-Therapy-Capsules.png&w=1920&q=75)
-Therapy-Capsules.png&w=1920&q=75)
Sodium Iodide (131I) Therapy Capsules